XML 64 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Assets        
Cash and cash equivalents $ 5,616,000,000 $ 2,117,000,000    
Receivables 147,000,000 152,000,000    
Inventories:        
Leaf tobacco 895,000,000 874,000,000    
Other raw materials 193,000,000 192,000,000    
Work in process 467,000,000 696,000,000    
Finished product 451,000,000 531,000,000    
Inventory, net 2,006,000,000 2,293,000,000    
Other current assets 166,000,000 262,000,000    
Total current assets 7,935,000,000 4,824,000,000    
Property, plant and equipment, at cost 5,103,000,000 5,074,000,000    
Less accumulated depreciation 3,106,000,000 3,075,000,000    
Property, plant and equipment, net 1,997,000,000 1,999,000,000    
Goodwill 5,177,000,000 5,177,000,000    
Other intangible assets, net 12,668,000,000 12,687,000,000    
Investments in equity securities 23,861,000,000 23,581,000,000    
Other assets 980,000,000 1,003,000,000    
Total Assets 52,618,000,000 49,271,000,000    
Liabilities        
Short-term borrowings 3,000,000,000.0 0    
Current portion of long-term debt 0 1,000,000,000    
Accounts payable 278,000,000 325,000,000    
Accrued liabilities:        
Marketing 467,000,000 393,000,000    
Settlement charges 4,419,000,000 3,346,000,000    
Other 1,032,000,000 1,533,000,000    
Income taxes 393,000,000 12,000,000    
Dividends payable 1,565,000,000 1,565,000,000    
Total current liabilities 11,154,000,000 8,174,000,000    
Long-term debt 26,971,000,000 27,042,000,000    
Deferred income taxes 5,191,000,000 5,083,000,000    
Accrued pension costs 427,000,000 473,000,000    
Accrued postretirement health care costs 1,798,000,000 1,797,000,000    
Other liabilities 402,000,000 345,000,000    
Total liabilities 45,943,000,000 42,914,000,000    
Contingencies (Note 11)    
Redeemable noncontrolling interest 38,000,000 38,000,000    
Stockholders’ Equity        
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935,000,000 935,000,000    
Additional paid-in capital 5,959,000,000 5,970,000,000    
Earnings reinvested in the business 36,528,000,000 36,539,000,000    
Accumulated other comprehensive losses (2,533,000,000) (2,864,000,000)    
Cost of repurchased stock (947,593,259 shares at March 31, 2020 and 947,979,763 shares at December 31, 2019) (34,346,000,000) (34,358,000,000)    
Total stockholders’ equity attributable to Altria 6,543,000,000 6,222,000,000    
Noncontrolling interests 94,000,000 97,000,000    
Total stockholders’ equity 6,637,000,000 6,319,000,000 $ 14,081,000,000 $ 14,789,000,000
Total Liabilities and Stockholders’ Equity $ 52,618,000,000 $ 49,271,000,000